Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Withdrawn

Conditions: Pulmonary Embolism
Cerebral Stroke
Thrombosis, Deep Vein

First Posted Date: 2019-01-15

Last Posted Date: 2021-11-22

Lead Sponsor: Pfizer

Registration Number: NCT03804125

Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease

Completed

Conditions: Inflammatory Bowel Disease (IBD)
Crohn's Disease (CD)
Ulcerative Colitis (UC)

Interventions: Drug: Inflectra

First Posted Date: 2019-01-14

Last Posted Date: 2021-03-02

Lead Sponsor: Pfizer

Target Recruit Count: 118

Registration Number: NCT03801928

Locations: 🇺🇸
San Diego Clinical Trials, San Diego, California, United States
🇺🇸
Medical Research Center Of Connecticut, LLC, Hamden, Connecticut, United States
🇨🇦
Montreal IBD Center (CMIIM), Montreal, Quebec, Canada

and more 12 locations

Bioequivalence Study of Tramadol Hydrochloride /Paracetamol Tablets Versus Ultracet Tablets

Phase 4

Completed

Conditions: Healthy

Interventions: Drug: Tramadol hydrochloride 37.5 mg/Paracetamol 325 mg tablets - tablet (Pfizer)
Drug: Ultracet Tablets

First Posted Date: 2019-01-14

Last Posted Date: 2019-07-17

Lead Sponsor: Pfizer

Target Recruit Count: 60

Registration Number: NCT03803371

Locations: 🇧🇷
ICF - Instituto de Ciencias Farmaceuticas de Estudos e Pesquisas Ltda, Aparecida de Goiania, GO, Brazil

JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis

Phase 3

Completed

Conditions: Atopic Dermatitis

Interventions: Drug: Placebo
Drug: PF-04965842
Drug: PF04965842

First Posted Date: 2019-01-08

Last Posted Date: 2022-04-13

Lead Sponsor: Pfizer

Target Recruit Count: 287

Registration Number: NCT03796676

Locations: 🇺🇸
UC Davis, Sacramento, California, United States
🇺🇸
AdventHealth Orlando, Orlando, Florida, United States
🇺🇸
Madera Family Medical Group, Madera, California, United States

and more 127 locations

Study of PF 04965842 Effect on MATE1/2K Activity in Healthy Participants

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Metformin
Drug: PF-04965842

First Posted Date: 2019-01-08

Last Posted Date: 2020-02-05

Lead Sponsor: Pfizer

Target Recruit Count: 12

Registration Number: NCT03796182

Locations: 🇧🇪
Pfizer Clinical Research Unit, Brussels, Belgium

Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.

Terminated

Conditions: Achondroplasia

First Posted Date: 2019-01-07

Last Posted Date: 2024-10-17

Lead Sponsor: Pfizer

Target Recruit Count: 315

Registration Number: NCT03794609

Locations: 🇺🇸
Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸
Texas Children Hospital, Houston, Texas, United States
🇺🇸
Boston Childrens Hospital, Boston, Massachusetts, United States

and more 51 locations

A Study Of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta Under Fed Conditions

Phase 4

Withdrawn

Conditions: Healthy

Interventions: Drug: Duloxetine hydrochloride capsule
Drug: Cymbalta capsule

First Posted Date: 2019-01-04

Last Posted Date: 2019-09-27

Lead Sponsor: Pfizer

Registration Number: NCT03794154

A Bioequivalence Study of Testosterone Cypionate in Hypogonadal Males

Phase 1

Completed

Conditions: Hypogonadism

Interventions: Biological: Test formulation
Biological: Reference formulation

First Posted Date: 2019-01-03

Last Posted Date: 2021-04-29

Lead Sponsor: Pfizer

Target Recruit Count: 74

Registration Number: NCT03792477

Locations: 🇺🇸
Avail Clinical Research, DeLand, Florida, United States
🇺🇸
Syneos Health, Miami, Florida, United States

A Study to Learn About the Drug-drug Interactions of Sisunatovir in Healthy Adult Participants

Phase 1

Completed

Conditions: Respiratory Syncytial Virus Infections

Interventions: Drug: Itraconazole
Drug: Verapamil
Drug: Rifampicin
Drug: Midazolam
Drug: RV521
Drug: Placebo for RV521

First Posted Date: 2018-12-20

Last Posted Date: 2024-04-22

Lead Sponsor: Pfizer

Target Recruit Count: 82

Registration Number: NCT03782662

Locations: 🇬🇧
Richmond Pharmacology Ltd, London, United Kingdom

Study To Describe The Safety Of 13-valent Pneumococcal Conjugate Vaccine In Children 6 To 17 Years Of Age In India

Phase 4

Completed

Conditions: Vaccines

Interventions: Biological: 13vPnC

First Posted Date: 2018-12-17

Last Posted Date: 2020-04-21

Lead Sponsor: Pfizer

Target Recruit Count: 100

Registration Number: NCT03777865

Locations: 🇮🇳
Manipal Hospital / Department of Pediatrics, Bengaluru, Karnataka, India
🇮🇳
KEM Hospital Research Centre, Pune, Maharashtra, India
🇮🇳
Christian Medical College, Ludhiana, Punjab, India

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy